Home > Product Development Planning
PRODUCT DEVELOPMENT PLANNING SERVICES
BioBoston CRO provides clinical development planning services for sponsors that need a practical roadmap connecting product strategy, evidence needs, study concepts, endpoints, vendors, timing, and early budget assumptions. The work is designed to make development choices visible before detailed execution begins.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
SERVICES
Develop or revise an integrated roadmap that connects target product considerations, evidence objectives,
studies, milestones, decision gates, dependencies, risks, and functional responsibilities.
Useful when the sponsor needs one reviewable plan for internal alignment, financing, authority
interactions, vendor scoping, or program governance.
Translate an approved study concept into a concise synopsis covering rationale, objectives, endpoints,
design, population, intervention or device use, assessments, analysis concepts, and major operational
assumptions.
Useful before full protocol writing, feasibility work, early vendor proposals, statistical planning, or regulatory
discussion.
Evaluate endpoint relevance, hierarchy, timing, measurement approach, interpretation, data burden,
feasibility, and connection to the development objective.
Useful when the program needs to compare endpoint options, reconcile stakeholder views, or prepare for
protocol and statistical decisions.
Define scope, requirements, request-for-proposal content, evaluation criteria, bid-defense questions,
decision records, and transition expectations for a Contract Research Organization or specialist vendor.
Useful when proposals are difficult to compare or when prior vendor selection relied mainly on cost,
relationships, or high-level capability statements.
Review early study assumptions, proposal structure, cost drivers, exclusions, pass-throughs, change-order
risks, and budget scenarios before commitment.
Useful during planning and vendor selection. Ongoing tracking, forecasting, invoice review, and change
order control should link to Project Management - Budget Tracking.
Common Triggers
Desired outcomes
Separate essential evidence and decisions from desirable activities that can be deferred, redesigned, or removed.
Give clinical, regulatory, statistical, operational, quality, data, and executive teams one documented set of assumptions and dependencies.
Define enough scope and decision criteria to request comparable proposals and evaluate whether a vendor can execute the plan.
Provide a baseline against which new data, feedback, feasibility, cost, and schedule changes can be evaluated.
RELATED SERVICES
Move from an approved synopsis or study concept to complete protocol authoring and controlled cross functional review.
Assess regulatory classification, pathway options, authority expectations, and route-to-market considerations that influence the development plan.
Evaluate sample size, design, endpoint, estimand, analysis, and statistical feasibility assumptions.
Manage the operational budget baseline, forecast, proposal changes, invoices, variances, and change orders after planning transitions to execution.
Manage performance, meetings, metrics, issues, and escalation after a Contract Research Organization or vendor is selected.
deliverables
Approach
BioBoston begins by defining the program decision, intended use of the plan, evidence already available,
constraints, stakeholders, and the maturity of each workstream. The goal is not to produce a static
presentation; it is to create a practical baseline that can guide decisions and reveal what remains
uncertain.
The sponsor retains responsibility for product, scientific, medical, regulatory, financial, and governance
decisions. BioBoston can facilitate the analysis, document options, identify dependencies, and coordinate
specialist input without presenting assumptions as approved facts.
Process
1. Confirm the product, indication or intended use, stage, target milestones, decision questions, stakeholders, and current planning materials.
2. Review available clinical, nonclinical, regulatory, statistical, operational, quality, data, commercial, and budget inputs; identify gaps and conflicts.
3. Develop the roadmap, study concept, endpoint options, vendor requirements, or budget-review framework included in scope.
4. Facilitate cross-functional review and document decisions, assumptions, risks, dependencies, and unresolved items.
5. Refine the plan against feasibility, timing, cost, regulatory feedback, and sponsor priorities.
6. Prepare the approved baseline and transition the relevant work to protocol writing, regulatory planning, vendor governance, budget tracking, or study execution.
Product development planning is most useful when several scientific, regulatory, clinical, operational, and financial decisions must be made together rather than in separate workstreams.
Create a coherent sequence of evidence, studies, decisions, vendors, and milestones before individual functions begin working from different assumptions.
Clarify study objectives, endpoints, protocol concept, evidence gaps, and decision questions before detailed authoring or vendor execution
Assess whether new data, feedback, feasibility, budget, timing, or vendor performance requires a revised development path
Expertise
Development-planning experience should match the product type, stage, evidence question, intended
market, study complexity, and decisions being made. Present the lead advisor and contributing specialists through approved profiles tied to the actual scope
PRACTICAL GUIDANCE
A planned guide to studies, evidence objectives, milestones, decision gates, dependencies, risks, and assumptions.
A planned checklist for design maturity, endpoints, population, assessments, analysis concepts, feasibility, and decision ownership.
A planned buyer guide for requirements, assumptions, pass-throughs, exclusions, bid defenses, risk, and selection records.
FAQs
The exact content depends on the program, but a useful plan normally connects evidence objectives,
planned studies, major milestones, decision gates, regulatory interactions, dependencies, risks,
assumptions, and functional responsibilities.
No. A synopsis establishes the approved study concept at a concise level. Protocol Writing owns complete authoring of the full protocol, including detailed sections, schedules, operational descriptions, and controlled review.
Yes. Support may include scope definition, request-for-proposal content, evaluation criteria, proposal
comparison, bid-defense preparation, risk assessment, and decision documentation. The sponsor remains responsible for selection and contracting.
Product Development Planning reviews early assumptions, proposals, cost drivers, and scenarios before or during selection. Project Management – Budget Tracking owns the ongoing baseline, forecast, variance, invoice, proposal-change, and change-order control during execution.
Yes. A development plan should function as a controlled baseline that can be revised when evidence,
feasibility, regulatory feedback, financing, timing, or strategy changes. The update should document what changed and why.
Useful inputs include product and indication information, existing data, prior plans and protocols, regulatory correspondence, target milestones, known constraints, vendor information, budget assumptions, and the names of decision owners.
PROJECT FORM
Share the product, development stage, evidence already available, decisions that need to be made, target milestone, and the planning support you need. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the product, development question, available evidence, next decision, constraints, and workstreams already in motion. BioBoston can then define the planning scope and the specialist inputs required to produce a decision-ready baseline.
